Compositions containing lipase; protease and amylase for treating pancreatic insufficiency
Details for Australian Patent Application No. 2005295754 (hide)
International Classifications
Event Publications
31 May 2007 PCT application entered the National Phase
PCT publication WO2006/044529 Priority application(s): WO2006/044529
30 October 2008 Amendment Made
The nature of the amendment is: Add Co-Inventor: Stevens, Anthony Christopher Lee
2 September 2010 Amendment Made
The nature of the amendment is as shown in the statement(s) filed 11 May 2007 2006
9 September 2010 Application Accepted
Published as AU-B-2005295754
14 October 2010 Assignment before Grant
Altus Pharmaceuticals Inc. The application has been assigned to Cystic Fibrosis Foundation Therapeutics, Inc.
13 January 2011 Standard Patent Sealed
9 June 2011 Assignment Registered
Cystic Fibrosis Foundation Therapeutics, Inc. The patent has been assigned to Eli Lilly and Co.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2005295756-Antisense modulation of PTP1B expression
2005295753-Pyrazole derivatives as phosphodiesterase 4 inhibitors
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser